Nastech Pharmaceutical Company Inc. - NSTK- Profile

Nastech Pharmaceutical Company Inc.. The Group's principal activity is to develop and market innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The Group uses this technology to create or utilize novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The intranasal drug delivery technology offers advantages over injectable routes for the administration of large molecules such as peptides and proteins. The Group develops a diverse portfolio of product candidates for multiple therapeutic areas including obesity, osteoporosis, breakthrough cancer pain, multiple sclerosis and erectile dysfunction. As of 31-Jan-2007, the Group had 36 patents issued and 296 pending foreign patent applications. Develops and markets innovative products based on proprietary molecular biology-based intranasal drug delivery technology